Historique de carrière de George G Nomikos
Anciens postes connus de George G Nomikos
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LIPOCINE INC. | Directeur Technique/Scientifique/R&D | 03/11/2022 | 01/04/2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur Technique/Scientifique/R&D | 05/09/2019 | 02/11/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/10/2007 | 01/10/2007 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2006 | 01/01/2006 |
| Karolinska Institutet | Corporate Officer/Principal | - | - |
| CYNAPSUS THERAPEUTICS INC | Directeur Technique/Scientifique/R&D | 30/10/2007 | - |
Formation de George G Nomikos
| National & Kapodistrian University of Athens | Doctorate Degree |
| University of British Columbia | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 3 |
| Grèce | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| LIPOCINE INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
- Bourse
- Insiders
- George G Nomikos
- Expérience